Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
The coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the synthetic pure glucocorticoid dexamethasone was identified as an effective compound for treatment of severe COVID-19. However,...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/13/6764 |
id |
doaj-b269010448c7450ab13aee02aae1858d |
---|---|
record_format |
Article |
spelling |
doaj-b269010448c7450ab13aee02aae1858d2021-07-15T15:36:40ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-06-01226764676410.3390/ijms22136764Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?Tomoshige Kino0Irina Burd1James H. Segars2Laboratory of Molecular and Genomic Endocrinology, Sidra Medicine, Doha 26999, QatarDepartment of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADepartment of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USAThe coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the synthetic pure glucocorticoid dexamethasone was identified as an effective compound for treatment of severe COVID-19. However, glucocorticoids are generally harmful for infectious diseases, such as bacterial sepsis and severe influenza pneumonia, which can develop respiratory failure and systemic inflammation similar to COVID-19. This apparent inconsistency suggests the presence of pathologic mechanism(s) unique to COVID-19 that renders this steroid effective. We review plausible mechanisms and advance the hypothesis that SARS-CoV-2 infection is accompanied by infected cell-specific glucocorticoid insensitivity as reported for some other viruses. This alteration in local glucocorticoid actions interferes with undesired glucocorticoid to facilitate viral replication but does not affect desired anti-inflammatory properties in non-infected organs/tissues. We postulate that the virus coincidentally causes glucocorticoid insensitivity in the process of modulating host cell activities for promoting its replication in infected cells. We explore this tenet focusing on SARS-CoV-2-encoding proteins and potential molecular mechanisms supporting this hypothetical glucocorticoid insensitivity unique to COVID-19 but not characteristic of other life-threatening viral diseases, probably due to a difference in specific virally-encoded molecules and host cell activities modulated by them.https://www.mdpi.com/1422-0067/22/13/6764glucocorticoidsglucocorticoid receptor (GR)inflammationinnate immunitysevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2)type I interferons (IFNs) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tomoshige Kino Irina Burd James H. Segars |
spellingShingle |
Tomoshige Kino Irina Burd James H. Segars Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? International Journal of Molecular Sciences glucocorticoids glucocorticoid receptor (GR) inflammation innate immunity severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) type I interferons (IFNs) |
author_facet |
Tomoshige Kino Irina Burd James H. Segars |
author_sort |
Tomoshige Kino |
title |
Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? |
title_short |
Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? |
title_full |
Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? |
title_fullStr |
Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? |
title_full_unstemmed |
Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? |
title_sort |
dexamethasone for severe covid-19: how does it work at cellular and molecular levels? |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-06-01 |
description |
The coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the synthetic pure glucocorticoid dexamethasone was identified as an effective compound for treatment of severe COVID-19. However, glucocorticoids are generally harmful for infectious diseases, such as bacterial sepsis and severe influenza pneumonia, which can develop respiratory failure and systemic inflammation similar to COVID-19. This apparent inconsistency suggests the presence of pathologic mechanism(s) unique to COVID-19 that renders this steroid effective. We review plausible mechanisms and advance the hypothesis that SARS-CoV-2 infection is accompanied by infected cell-specific glucocorticoid insensitivity as reported for some other viruses. This alteration in local glucocorticoid actions interferes with undesired glucocorticoid to facilitate viral replication but does not affect desired anti-inflammatory properties in non-infected organs/tissues. We postulate that the virus coincidentally causes glucocorticoid insensitivity in the process of modulating host cell activities for promoting its replication in infected cells. We explore this tenet focusing on SARS-CoV-2-encoding proteins and potential molecular mechanisms supporting this hypothetical glucocorticoid insensitivity unique to COVID-19 but not characteristic of other life-threatening viral diseases, probably due to a difference in specific virally-encoded molecules and host cell activities modulated by them. |
topic |
glucocorticoids glucocorticoid receptor (GR) inflammation innate immunity severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) type I interferons (IFNs) |
url |
https://www.mdpi.com/1422-0067/22/13/6764 |
work_keys_str_mv |
AT tomoshigekino dexamethasoneforseverecovid19howdoesitworkatcellularandmolecularlevels AT irinaburd dexamethasoneforseverecovid19howdoesitworkatcellularandmolecularlevels AT jameshsegars dexamethasoneforseverecovid19howdoesitworkatcellularandmolecularlevels |
_version_ |
1721299358377312256 |